TY  - JOUR 
AU  - Rodríguez, J. A.
AU  - Sobrino Moreiras, Tomas
AU  - Orbe, J.
AU  - Purroy, A.
AU  - Martínez-Vila, E.
AU  - Castillo Sánchez, José
AU  - Páramo, J. A.
PY  - 2013
SN  - 1538-7933
UR  - http://hdl.handle.net/20.500.11940/3719
AB  - BACKGROUND: Matrix metalloproteinases (MMPs) mediate tissue injury during stroke but also neurovascular remodeling and we have shown that MMP-10 is involved in atherothrombosis. OBJECTIVE: The purpose of this study was to examine the relationship...
LA  - eng
KW  - Aged
KW  - Biomarkers
KW  - Brain Ischemia
KW  - Cohort Studies
KW  - Female
KW  - Gene Expression Regulation
KW  - Human Umbilical Vein Endothelial Cells
KW  - Humans
KW  - Inflammation
KW  - Male
KW  - Matrix Metalloproteinase 10
KW  - Middle Aged
KW  - Prospective Studies
KW  - Real-Time Polymerase Chain Reaction
KW  - Risk Assessment
KW  - Severity of Illness Index
KW  - Stroke
KW  - Thrombosis/metabolism
KW  - Time Factors
KW  - Tissue Plasminogen Activator
KW  - Treatment Outcome
KW  - Tumor Necrosis Factor-alpha
KW  - biological markers
KW  - matrix metalloproteinases
KW  - stroke
KW  - tumor necrosis factor-alpha
TI  - proMetalloproteinase-10 is associated with brain damage and clinical outcome in acute ischemic stroke
DO  - 10.1111/jth.12312
T2  - JOURNAL OF THROMBOSIS AND HAEMOSTASIS
M2  - 1464
VL  - 11
ER  -